EpiVax
Providence, RI, United States epivax.com
From their website, Nov 2026
Work here? Claim this listing
About
EpiVax provides immunogenicity assessment services for biologic and vaccine developers. It combines in silico analysis, in vitro assays, and consulting to support programs from early discovery through regulatory submission. The company is based in Providence, Rhode Island, USA.
Services
ISPRI™ Downselect™
In silico service that helps identify candidates with the lowest immunogenic risk early in development.
Assays & in vitro testing
ISPRI™ Quantify™
In silico service for assessing overall and regional immunogenic and tolerogenic potential in therapeutic sequences.
Assays & in vitro testing
ISPRI™ Analyze™
In silico service for therapeutic immunogenicity analysis within the ISPRI toolkit.
Assays & in vitro testing
ISPRI™ Evaluate™
In silico service for therapeutic immunogenicity evaluation within the ISPRI toolkit.
Assays & in vitro testing
ISPRI-HCP™
In silico service focused on immunogenicity-related analysis within the ISPRI toolkit.
Assays & in vitro testing
ISPRI™ Design™
In silico service for optimizing protein regions and supporting peptide design for testing.
Assays & in vitro testing
PANDA® Screening
In silico screening service related to immunogenicity assessment.
Assays & in vitro testing
iVAX™
Web-based computational vaccine design toolkit for epitope mapping, antigen selection, immunogen design, and vaccine efficacy prediction.
Assays & in vitro testing
EpiCC™
Fee-for-service vaccine analysis offered as part of the vaccine in silico services.
Assays & in vitro testing
PreVAX™
Fee-for-service vaccine analysis offered as part of the vaccine in silico services.
Assays & in vitro testing
All In Vitro Assays
Experimental in vitro assays used to validate in silico predictions and assess immunogenicity factors.
Assays & in vitro testing
Class II HLA Binding Assay
Cell-free in vitro assay that measures relative binding affinity of putative HLA ligands using recombinant Class II HLA-DR supertype alleles.
Assays & in vitro testing
Generic Peptide PANDA® Assays
Assays for assessing immunogenic potential of generic peptide APIs and associated impurities.
Assays & in vitro testing
Trusted Expert Advice (TEA)
Consulting service providing expert immunogenicity advice across development programs.
IRA / ISI Regulatory Writing Support
Regulatory writing support for immunogenicity risk assessment and integrated summaries.
Capabilities
- Assays and studies
- Immunogenicity · Peptides · Antibodies · Cell-free expression · ADCs · Cell-free in vitro assay · Competition-based assay · HLA binding assay · In vitro validation assay · Immunogenicity assessment · T cell epitope mapping · Epitope density analysis
- Scale and capacity
- 13M+ sequences analyzed
- Therapeutic areas
- Immunogenicity assessment · Therapeutic development · Vaccine design · Regulatory strategy · Biologics · Antibody-drug conjugates · Infectious disease · Cancer
Instruments and platforms
- BLAST
Modalities and species
- Modalities
- Small molecule · Antibody · ADC · Peptide · Vaccine
- Species and models
- Humans · Livestock
Certifications
As the company states them, with the certificate or registry record where there is one.
GMPSelf-reported
Company
- Type
- CRO
- Ownership
- Woman-owned, as registered with SAM.gov or stated on their site
Locations
- Address
- 188 Valley Street, Suite 424 Providence, RI 02909, USA
- Sites
- Providence, USA
- Serves
- USA
Similar labs
Work here? Claim this listing